Fennec Pharmaceuticals Inc (FRX)

Currency in CAD
11.01
-0.39(-3.42%)
Closed·
FRX Scorecard
Full Analysis
Net income is expected to grow this year
FRX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
10.9111.01
52 wk Range
5.6512.99
Key Statistics
Bid/Ask
8.00 / 12.20
Prev. Close
11.01
Open
10.91
Day's Range
10.91-11.01
52 wk Range
5.65-12.99
Volume
300
Average Volume (3m)
730
1-Year Change
37.97%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
FRX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Fennec Pharmaceuticals Inc Company Profile

Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company’s product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Employees
32
Market
Canada

Compare FRX to Peers and Sector

Metrics to compare
FRX
Peers
Sector
Relationship
P/E Ratio
−16.0x−1.2x−0.5x
PEG Ratio
0.03−0.060.00
Price/Book
−39.3x2.2x2.6x
Price / LTM Sales
7.5x10.3x3.3x
Upside (Analyst Target)
-291.0%43.5%
Fair Value Upside
Unlock22.7%6.3%Unlock

Earnings

Latest Release
May 13, 2025
EPS / Forecast
-0.04 / -0.095
Revenue / Forecast
8.75M / 8.10M
EPS Revisions
Last 90 days

FRX Income Statement

FAQ

What Stock Exchange Does Fennec Pharma Trade On?

Fennec Pharma is listed and trades on the Toronto Stock Exchange stock exchange.

What Is the Stock Symbol for Fennec Pharma?

The stock symbol for Fennec Pharma is "FRX."

What Is the Fennec Pharma Market Cap?

As of today, Fennec Pharma market cap is 316.76M.

What Is Fennec Pharma's Earnings Per Share (TTM)?

The Fennec Pharma EPS (TTM) is -0.53.

When Is the Next Fennec Pharma Earnings Date?

Fennec Pharma will release its next earnings report on 06 Aug 2025.

From a Technical Analysis Perspective, Is FRX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Fennec Pharma Stock Split?

Fennec Pharma has split 3 times.

How Many Employees Does Fennec Pharma Have?

Fennec Pharma has 32 employees.

What is the current trading status of Fennec Pharma (FRX)?

As of 05 Aug 2025, Fennec Pharma (FRX) is trading at a price of 11.01, with a previous close of 11.01. The stock has fluctuated within a day range of 10.91 to 11.01, while its 52-week range spans from 5.65 to 12.99.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.